Floatz logo

Gnc-038

Vascular Immunomother T Cell Lymphoma

Sichuan Baili Pharmaceutical Co., Ltd.monoclonal_antibodyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

54 Active assets in the Vascular Immunomother T Cell Lymphoma cohort.

Asset / SponsorPhaseRating
Ifosfamide
Shandong Provincial Hospital
Phase 4BBB
DEXAMETHASONE
Ou Bai, MD/PHD
Phase 2BB
ETOPOSIDE
Eric Jacobsen, MD
Phase 4BB
Romidepsin
The Lymphoma Academic Research Organisation
Phase 3BB
Inno-206
City of Hope Medical Center
Phase 4BB

View all 50 →

Same molecule, other indications

Gnc-038 is also rated in:

non-Hodgkin lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
extranodal nasal NK/T cell lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
primary central nervous system lymphomaDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →